热门出版物 - 学术资源搜索

h5 指数:76
h5 中位数:109

h5 指数是指在过去整整 5 年中所发表文章的 h 指数。h 指在 2018-2022 年间发表的 h 篇文章每篇至少都被引用过 h 次的最大值。隐藏

出版物的 h5 中位数，是指出版物的 h5 指数所涵盖的所有文章获得的引用次数的中位值。隐藏

#11 Gastroenterology & Hepatology

标题/作者	引用次数	年份
gastrointestinal features in COVID‐19 and the possibility of faecal transmission Y Tian, L Rong, W Nian, Y He Alimentary Pharmacology & Therapeutics 51 (9), 843-851	1055	2020
Systematic review with meta‐analysis: the worldwide prevalence of Helicobacter pylori infection M Zamani, F Ebrahimtabar, V Zamani, WH Miller, R Alizadeh‐Navaei, ... Alimentary Pharmacology & Therapeutics 47 (7), 868-876	638	2018
Systematic review with meta‐analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome AC Ford, LA Harris, BE Lacy, EMM Quigley, P Moayyedi Alimentary Pharmacology & Therapeutics 48 (10), 1044-1060	418	2018
short chain fatty acids as potential therapeutic agents in human gastrointestinal and inflammatory disorders PA Gill, MC van Zelm, JG Muir, PR Gibson Alimentary Pharmacology & Therapeutics 48 (1), 15-34	344	2018
low population mortality from COVID-19 in countries south of latitude 35 degrees North supports vitamin D as a factor determining severity. JM Rhodes, S Subramanian, E Laird, RA Kenny Alimentary Pharmacology & Therapeutics 51 (12), 1434-1437	294	2020
Systematic review with meta‐analysis: liver manifestations and outcomes in COVID‐19 AV Kulkarni, P Kumar, HV Tevethia, M Premkumar, JP Arab, R Candia, ... Alimentary Pharmacology & Therapeutics 52 (4), 584-599	230	2020
Systematic review with meta‐analysis: risk of hepatocellular carcinoma in non‐alcoholic steatohepatitis without cirrhosis compared to other liver diseases JG Stine, BJ Wentworth, A Zimmet, ME Rinella, R Loomba, SH Caldwell, ... Alimentary Pharmacology & Therapeutics 48 (7), 696-703	227	2018
Systematic review with network meta‐analysis: first‐and second‐line pharmacotherapy for moderate‐severe ulcerative colitis S Singh, M Fumery, WJ Sandborn, MH Murad Alimentary Pharmacology & Therapeutics 47 (2), 162-175	218	2018
Systematic review with meta‐analysis: the prevalence of anxiety and depression in patients with irritable bowel syndrome M Zamani, S Alizadeh‐Tabari, V Zamani Alimentary Pharmacology & Therapeutics 50 (2), 132-143	218	2019
Systematic review: human gut dysbiosis induced by non‐antibiotic prescription medications Q Le Bastard, GA Al‐Ghalith, M Grégoire, G Chapelet, F Javaudin, ... Alimentary Pharmacology & Therapeutics 47 (3), 332-345	202	2018
hepatitis B core‐related antigen (HB crAg): an emerging marker for chronic hepatitis B virus infection LY Mak, DKH Wong, KS Cheung, WK Seto, CL Lai, MF Yuen Alimentary Pharmacology & Therapeutics 47 (1), 43-54	198	2018
the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease CA Woodhouse, VC Patel, A Singanayagam, DL Shawcross Alimentary Pharmacology & Therapeutics 47 (2), 192-202	191	2018
COVID‐19 and liver disease—what we know on 1st May 2020 I Garrido, R Liberal, G Macedo Alimentary Pharmacology & Therapeutics 52 (2), 267-275	188	2020
Covid-19, and vitamin D. A Panarese, E Shahini Alimentary Pharmacology & Therapeutics 51 (10), 993-995	185	2020
the gut microbiome in inflammatory bowel disease—avenues for microbial management J McIlroy, G Ianiro, I Mukhopadhya, R Hansen, GL Hold Alimentary Pharmacology & Therapeutics 47 (1), 26-42	182	2018
2019 novel coronavirus disease (COVID‐19) in patients with inflammatory bowel diseases C Taxonera, I Sagastagoitia, C Alba, N Mañas, D Olivares, E Rey Alimentary Pharmacology & Therapeutics 52 (2), 276-283	180	2020
Systematic review and network meta‐analysis: first‐and second‐line biologic therapies for moderate‐severe Crohn's disease S Singh, M Fumery, WJ Sandborn, MH Murad Alimentary Pharmacology & Therapeutics 48 (4), 394-409	175	2018
Systematic review with meta‐analysis: the growing incidence and prevalence of eosinophilic oesophagitis in children and adults in population‐based studies P Navarro, Á Arias, L Arias‐González, EJ Laserna‐Mendieta, ... Alimentary Pharmacology & Therapeutics 49 (9), 1116-1125	169	2019
Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication‐a prospective study for up to 10 years YJ Hwang, N Kim, HS Lee, JB Lee, YJ Choi, H Yoon, CM Shin, YS Park, ... Alimentary Pharmacology & Therapeutics 47 (3), 380-390	169	2018
Systematic review with meta‐analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome G Ianiro, LH Eusebi, CJ Black, A Gasbarrini, G Cammarota, AC Ford Alimentary Pharmacology & Therapeutics 50 (3), 240-248	157	2019

1 - 20

计算机程序会自动估算并确定日期和引用次数。